Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

Journal:

Science Translational Medicine

Published:

2025-07-30

DOI:

10.1126/scitranslmed.ady6831

Affiliations:

22

Authors:

50

Go to article

Institutions	Authors	Share
Fred Hutchinson Cancer Center, United States of America (USA)	16.000000 16.000000	0.32
Scripps Research, United States of America (USA)	7.833333	0.16
Moderna, United States of America (USA)	4.250000	0.09
Duke University, United States of America (USA)	3.000000	0.06
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	2.000000	0.04
University of Washington (UW), United States of America (USA)	2.000000	0.04
Duke University Health System, United States of America (USA)	2.000000	0.04
Brigham and Women's Hospital (BWH), United States of America (USA)	2.000000	0.04
IAVI's Neutralizing Antibody Center (NAC), United States of America (USA)	1.916667	0.04
International AIDS Vaccine Initiative (IAVI), United States of America (USA)	1.000000	0.02
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.02
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.02
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.02
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	1.000000	0.02
New York Blood Center (NYBC), United States of America (USA)	1.000000	0.02
University of Rochester (UR), United States of America (USA)	1.000000	0.02
UCLA Health, United States of America (USA)	1.000000	0.02
Health Sciences, Pitt, United States of America (USA)	1.000000	0.02

Interested in Clinical Sciences?